Your session is about to expire
← Back to Search
Poziotinib for Non-Small Cell Lung Cancer
Study Summary
This trial is for patients who have responded to or are still receiving benefits from poziotinib treatment and would like to continue treatment.
- Non-Small Cell Lung Cancer
- Breast Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 2 trial • 67 Patients • NCT02659514Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has Poziotinib been granted governmental authorization for therapeutic use?
"While there are some studies supporting the safety of Poziotinib, a lack of evidence to back up its efficacy means it earned a score of 2 on our evaluation scale."
Is this a pioneering research endeavor?
"At the moment, 5 trials for Poziotinib are underway in 49 cities and 9 nations. The earliest of these dates back to 2017 when Spectrum Pharmaceuticals, Inc conducted a Phase 2 drug approval study with 80 volunteers; since then 11 more experiments have been concluded."
Have other research projects investigated the effect of Poziotinib?
"Presently, five distinct clinical studies are looking into the potential of poziotinib. As yet, none of these trials have reached phase 3 and 73 different sites across Shreveport, Louisiana offer research for this treatment."
How many participants have registered for the experiment so far?
"This clinical trial is no longer recruiting; the last update was October 31st 2022. However, there are a multitude of other medical trials seeking candidates - 2047 concerning breast cancer and 5 for Poziotinib particularly."
Is recruitment for this experiment still underway?
"Data posted on clinicaltrials.gov states that this study is not actively searching for candidates at the moment, though it was initially listed on October 5th 2018 and last updated in October 31st 2022. Nonetheless, there are currently 2052 other medical trials that are recruiting participants."
Share this study with friends
Copy Link
Messenger